Angela D'Angelo Selected Research

Apoprotein(a) (Apolipoprotein (a))

3/2022	Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study.
4/2005	Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
12/2004	Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
2/2004	Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
2/2004	Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
12/2003	Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela D'Angelo Research Topics

Disease

43	Insulin Resistance 01/2022 - 01/2006
32	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2006
27	Body Weight (Weight, Body) 01/2021 - 01/2009
20	Inflammation (Inflammations) 01/2021 - 07/2003
13	Hypertension (High Blood Pressure) 03/2021 - 03/2003
6	Overweight 05/2016 - 12/2003
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2015 - 05/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 02/2011
5	Chronic Kidney Failure (Chronic Renal Failure) 11/2015 - 01/2006
4	Coronary Disease (Coronary Heart Disease) 11/2020 - 12/2003
4	Glucose Intolerance 09/2020 - 01/2006
4	Vascular Calcification 08/2013 - 11/2011
4	Fibrosis (Cirrhosis) 01/2012 - 01/2002
4	Secondary Hyperparathyroidism 01/2011 - 10/2002
4	Acute Coronary Syndrome 11/2007 - 12/2004
3	Hyperlipidemias (Hyperlipidemia) 01/2022 - 07/2014
3	Dyslipidemias (Dyslipidemia) 11/2020 - 04/2009
3	Atrial Fibrillation 04/2017 - 11/2011
3	Essential Hypertension 02/2014 - 09/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013 - 05/2005
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2012 - 07/2003
3	Alzheimer Disease (Alzheimer's Disease) 11/2005 - 02/2004
3	Atherosclerosis 11/2005 - 02/2005
2	Vitamin D Deficiency 03/2022 - 04/2010
2	COVID-19 03/2021 - 01/2021
2	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 10/2015
2	Nausea 01/2020 - 03/2009
2	Pain (Aches) 01/2019 - 10/2013
2	Nephrocalcinosis 04/2015 - 09/2009
2	Medullary Sponge Kidney 04/2015 - 07/2010

Drug/Important Bio-Agent (IBA)

32	Insulin (Novolin)FDA Link 03/2022 - 01/2006
31	LipidsIBA 01/2021 - 01/2006
30	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2006
21	C-Reactive ProteinIBA 09/2020 - 04/2006
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2004
16	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 04/2007
16	Metformin (Glucophage)FDA LinkGeneric 01/2017 - 01/2007
15	ResistinIBA 01/2021 - 05/2008
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 11/2006
11	AdiponectinIBA 01/2020 - 05/2008
10	oxidized low density lipoproteinIBA 01/2022 - 01/2006
10	Nicotinamide PhosphoribosyltransferaseIBA 01/2021 - 01/2010
9	HDL CholesterolIBA 11/2020 - 01/2006
9	Vitamin A (Retinol)FDA LinkGeneric 05/2015 - 01/2010
8	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022 - 08/2009
8	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2006
8	CholesterolIBA 11/2020 - 01/2006
8	LDL CholesterolIBA 11/2020 - 01/2006
8	Pioglitazone (Actos)FDA Link 09/2013 - 05/2006
7	Receptor for Advanced Glycation End ProductsIBA 01/2020 - 05/2005
7	Acarbose FDA LinkGeneric 01/2017 - 01/2006
7	CalciumIBA 02/2016 - 12/2004
6	Lipoprotein(a)IBA 03/2022 - 12/2003
6	Apoprotein(a) (Apolipoprotein (a))IBA 03/2022 - 12/2003
6	Apolipoproteins AIBA 03/2022 - 12/2003
6	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 05/2006
6	Sitagliptin Phosphate (Januvia)FDA Link 10/2019 - 06/2010
6	Proteins (Proteins, Gene)FDA Link 01/2015 - 03/2003
5	Protein Isoforms (Isoforms)IBA 03/2022 - 12/2003
5	AdipokinesIBA 01/2021 - 12/2012
5	AlbuminsIBA 01/2018 - 03/2003
5	Amlodipine (Norvasc)FDA LinkGeneric 07/2015 - 01/2013
5	Metalloproteases (Metalloproteinases)IBA 02/2015 - 01/2007
5	olmesartanIBA 01/2014 - 08/2010
5	LeptinIBA 10/2011 - 11/2006
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 03/2010
4	CanrenoneIBA 01/2018 - 11/2013
4	VildagliptinIBA 11/2015 - 12/2012
4	Glucagon (Glukagon)FDA Link 07/2014 - 12/2012
4	ProinsulinIBA 07/2014 - 06/2010
4	Carnitine (L-Carnitine)FDA LinkGeneric 10/2011 - 01/2010
4	sibutramine (Meridia)FDA Link 03/2011 - 11/2008
4	Rosiglitazone (Avandia)FDA Link 05/2008 - 05/2006
3	Vitamin D FDA LinkGeneric 03/2022 - 01/2011
3	AldosteroneIBA 01/2018 - 11/2013
3	Angiotensin Receptor AntagonistsIBA 01/2018 - 04/2007
3	Ramipril (Altace)FDA LinkGeneric 04/2017 - 01/2011
3	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2015 - 01/2011
3	Glyburide (Glibenclamide)FDA LinkGeneric 09/2013 - 01/2007
3	Pharmaceutical PreparationsIBA 01/2013 - 05/2008
3	Orlistat (Xenical)FDA Link 10/2011 - 01/2010
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2011 - 05/2006
2	HomocysteineIBA 01/2021 - 05/2006
2	CytokinesIBA 01/2020 - 06/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2015
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018 - 04/2017
2	PotassiumIBA 01/2018 - 02/2015
2	hydroxide ionIBA 12/2016 - 07/2013
2	lercanidipineIBA 04/2016 - 08/2015
2	Losartan (Cozaar)FDA LinkGeneric 04/2016 - 01/2011
2	mepirodipine (barnidipine)IBA 04/2016 - 08/2015
2	Angiotensin II Type 1 Receptor BlockersIBA 02/2016 - 02/2014
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2015 - 07/2010
2	glimepiride (Amarel)FDA LinkGeneric 07/2014 - 05/2006
2	InterleukinsIBA 09/2013 - 01/2013
2	Warfarin (Coumadin)FDA LinkGeneric 08/2013 - 11/2011

Therapy/Procedure

25	Therapeutics 01/2022 - 04/2006
20	Glycemic Control 01/2017 - 05/2006
5	Renal Dialysis (Hemodialysis) 07/2013 - 03/2004
3	Kidney Transplantation 04/2010 - 10/2002